Werewolf Therapeutics, Inc.
HOWL
$0.919
$0.0718.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.52M | -62.12M | -53.73M | -41.58M | -37.37M |
| Total Depreciation and Amortization | 1.81M | 1.83M | 1.82M | 1.80M | 1.76M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 60.00K |
| Total Other Non-Cash Items | 9.99M | 9.66M | 9.85M | 10.16M | 8.83M |
| Change in Net Operating Assets | 2.53M | 4.11M | 787.00K | -8.40M | -5.89M |
| Cash from Operations | -56.19M | -46.52M | -41.27M | -38.01M | -32.61M |
| Capital Expenditure | -254.00K | -329.00K | -547.00K | -712.00K | -769.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -254.00K | -329.00K | -547.00K | -712.00K | -769.00K |
| Total Debt Issued | 30.00M | 30.00M | 30.00M | 0.00 | 40.00M |
| Total Debt Repaid | -40.00M | -40.00M | -40.00M | -- | -- |
| Issuance of Common Stock | 23.76M | 30.29M | 30.33M | 30.07M | 18.43M |
| Repurchase of Common Stock | -6.00K | -6.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -673.00K | -673.00K | -673.00K | -- | -- |
| Cash from Financing | 13.08M | 19.61M | 19.65M | 30.07M | 58.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.36M | -27.24M | -22.16M | -8.66M | 25.05M |